Medtronic Launches CareLink Pro 3.0

Medtronic, Inc. Monday announced the Food and Drug Administration (FDA) approval and the market launch of CareLink Pro 3.0 Therapy Management Software, the first software program to offer advanced decision support to healthcare professionals managing diabetes.
Canada